Aytu BioPharma, Inc. revenue breakdown overview

Aytu BioPharma, Inc. revenue for the last year amounted to 107.40 M USD, the most of which — 73.80 M USD — came from its highest performing source at the moment, Aytu Bioscience, the year earlier bringing 61.12 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Aytu BioPharma, Inc. 106.92 M USD, and the year before that — 94.61 M USD.